Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.538,31
-0,50%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Addex Therapeutics Ltd (ADXN) Addex Therapeutics Ltd (ADXN) Notizie

Addex Therapeutics Ltd

ADXN
7,53
-0,58 (-7,15%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202407:00GLOBEAddex Reports Third Quarter 2024 Financial Results and..
11/11/202407:00GLOBEAddex Provisional 2024 Third Quarter Results Showed Net Loss..
30/9/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/9/202407:00GLOBEAddex Therapeutics Reports 2024 Half Year and Second Quarter..
19/9/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202407:00GLOBEAddex Provisional 2024 Half-Year and Second Quarter Result..
04/9/202407:00GLOBEAddex to Participate in the H.C. Wainwright 26th Annual..
27/8/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/8/202407:00GLOBEAddex and Indivior Select Clinical Candidates from GABAB..
15/8/202402:12EDGAR2Form SC 13D/A - General Statement of Acquisition of..
06/8/202403:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
22/7/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/7/202407:00GLOBEAddex’s Partner Discontinues ADX71149 development in..
15/7/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/7/202407:00GLOBEAddex Presents Positive Results from GABAB PAM Cough Program..
12/7/202407:00GLOBEAddex To Present at the Thirteenth London International..
01/7/202407:00GLOBEAddex Shareholders Approve All Resolutions at Annual General..
06/6/202413:29IHMARKETNEWSUS Index Futures Mixed; Oil Prices Rise
06/6/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202407:00GLOBEAddex Therapeutics Reports Q1 2024 Financial Results and..
05/6/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/6/202407:00GLOBEAddex Convenes Annual General Meeting 2024
31/5/202407:00GLOBEAddex Therapeutics to Release Q1 2024 Financial Results and..
08/5/202407:00GLOBEAddex to Present at Bio€quity Europe 2024
29/4/202407:00GLOBEAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
19/4/202407:00GLOBEAddex to Present at the Swiss Biotech Day 2024
18/4/202407:00GLOBEAddex Therapeutics Reports Full Year 2023 Financial Results..
11/4/202407:00GLOBEAddex Therapeutics to Release Full-Year 2023 Financial..
03/4/202407:00GLOBEAddex and Perceptive Launch Neurosterix with $63 Million to..
14/3/202407:00GLOBEAddex to Present at the Bio-Europe Spring 2024 Conference
31/1/202407:00GLOBEAddex Enters into At-The-Market ADS Offering Agreement with..
30/1/202423:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/1/202422:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202407:00GLOBEAddex to Present at the Swiss Equities Baader Conference
05/1/202407:30GLOBEAddex to Present at Biotech Showcase™ 2024
21/12/202312:00EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
20/12/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202307:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
14/12/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202307:00GLOBEAddex Creates Treasury Shares
08/12/202320:11EDGAR2Form SC 13D/A - General statement of acquisition of..
30/11/202322:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
29/11/202322:00EDGAR2Form SC 13D/A - General statement of acquisition of..
29/11/202312:27EDGAR2Form POS AM - Post-Effective amendments for registration..
29/11/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202307:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
28/11/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202307:00GLOBEAddex Convenes Extraordinary General Meeting
Apertura: 8,00 Min: 7,01 Max: 8,9799
Chiusura: 8,11

La tua Cronologia

NASDAQ
ADXN
Addex Therapeutics
NYSE
WES
Western Midstream Partners
LSE
JEMA
Jpmorgan Emerging Europe...
AQSE
CIA
Clean Invest Africa
LSE
0RH3
Singulus Technologies
AQSE
CLIG.GB
City of London Investment
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network